A treatment that specifically increases Tregs may be useful for the treatment of insulin resistance (29), and pioglitazone, a drug used to treat T2D, can increase insulin sensitivity by stimulating PPAR-γ signaling in Tregs, resulting in an increased frequency of Tregs in adipose tissue (30). Here, INS is linked to Insulin resistance.